Mounjaro 7.5mg Injection

It’s normal to feel a bit hungrier at times, even at 7.5mg. Your body may be adjusting to the dose, or your hunger could be linked to things like stress, poor sleep, or not getting enough protein and fibre. Sometimes it can take some time to find the right dose for you, so be patient and kind to yourself during this titration stage. Try increasing protein consumption, staying hydrated, and ensuring consistent injection timing for better appetite control. If your appetite feels harder to manage, speak to your clinician, there may be ways to adjust your plan or consider the next dose when appropriate.

Weight loss varies from person to person, but clinical research tells us that by week 12, most people on Mounjaro will have lost around 8% of their starting weight. Progress can continue at 7.5mg, especially when paired with healthy eating, regular movement, and support from the programme. Your results will depend on your starting point, lifestyle, and how your body responds.

Mounjaro 7.5mg is a step-up dose. It’s designed to help your body adjust to the medication while providing stronger appetite suppression and blood sugar regulation than lower doses (2.5mg and 5mg).

• Stronger than lower doses – Helps enhance weight loss and reduce cravings.
• Not the highest dose – Higher doses (10mg, 12.5mg, and 15mg) may be needed for some people to achieve their weight loss goals.
• Effectiveness varies – Some people find 7.5mg sufficient, while others may require higher doses for continued progress.

As a step-up dose, 7.5mg is part of the gradual titration schedule to minimise side effects and optimise results. If it isn't strong enough, ask your clinician about dose adjustments.

The Mounjaro 7.5mg pen contains four doses (one per week), so it should last four weeks. It’s a pre-set pen, so there’s no need to count clicks.

Each 7.5 mg dose of Mounjaro (tirzepatide) is delivered in 0.6 mL of solution via the KwikPen. The multi-dose pre-filled pen can deliver 2.4 mL of solution, providing four weekly doses of 0.6 mL each.

Mounjaro 7.5mg is administered once weekly via subcutaneous injection. Choose the same day each week for consistency, injecting into the abdomen, thigh, or upper arm as directed by your clinician.

Both doses contain tirzepatide and work in the same way, but 7.5mg delivers a slightly higher amount to enhance appetite control, blood sugar regulation, and weight loss. It’s typically the next step up after completing at least 4 weeks on 5mg.

Many people find that 7.5mg is an effective maintenance dose. If this dose is working well for you, you can continue with it. However, some may need to increase to 10mg for continued results. Your clinician will assess your progress and recommend the best path forward.

Typically, remain on 7.5mg for at least 4 weeks before considering an increase. If you're achieving good results with manageable side effects, staying longer at this dose is perfectly acceptable.

Mounjaro 7.5mg treats type 2 diabetes and supports weight management by activating GIP and GLP-1 receptors. This dual action slows digestion, increases insulin production, reduces appetite, and helps regulate blood sugar levels.

Yes, Mounjaro is licensed for use in weight management in patients with or with diabetes. Clinical evidence supports its effectiveness for weight loss in individuals with or without diabetes when combined with lifestyle modifications.

Currently, Mounjaro is primarily available through private prescriptions in the UK. NHS availability is limited to specific diabetes patients who meet strict criteria, or through Tier 3 weight management services via your GP. For weight management, private prescriptions remain the main access route.